ENDRA Life Sciences's total assets for Q2 2025 were $2.81M, a decrease of -11.45% from the previous quarter. NDRA total liabilities were $1.33M for the fiscal quarter, a -5.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.